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This protocol describes a pragmatic multicentre randomised controlled trial (RCT) to assess 
the clinical and cost effectiveness of arthroscopic and open surgery in the management of 
rotator cuff tears. This trial began in 2007 and was modified in 2010, with the removal of a 
non-operative arm due to high rates of early crossover to surgery. 
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Introduction
In 2000, an assessment of the prevalence and
incidence of consultations for shoulder prob-
lems in UK primary care estimated the annual
prevalence to be 2.4%, with the rate increasing
linearly with age.1 It is estimated that disorders
of the rotator cuff account for between 30%
and 70% of the shoulder pain cases that are
reported.2,3 The clinical evidence available,
regarding both the natural history and manage-
ment of rotator cuff tears, is limited and conflict-
ing; most reports are small scale, (< 50 cases),
single-centre, retrospective cohort studies.4-11 
Rotator cuff tears can be treated both sur-
gically (arthroscopic and open) and non-sur-
gically (for example by injection and
exercises). Traumatic tears are uncommon:
most patients present through age-related
degeneration of tendon attachment to bone
at the proximal humerus. Surgical repair may
be considered for patients with persistent
symptoms who fail to respond to rest and
conservative care. Such non-operative care
will usually include physiotherapy and gluco-
corticoid injections into the shoulder. 
A rotator cuff repair operation aims to re-
attach the tendons to the bone. The repair
may also include an acromioplasty, where
overhanging bone and soft tissue above the
tendon are excised, with the aim of creating
more space for the rotator cuff tendons to
move freely. 
In general, two approaches are available
for surgical repair:
 Open/mini-open surgery involves the
rotator cuff being repaired under direct
vision through an incision in the skin.
 Arthroscopic surgery involves the repair
being performed through arthroscopic
portals. 
Proponents of arthroscopic rotator cuff sur-
gery suggest that the procedure may have
advantages over standard open techniques,
in that the resulting trauma to the deltoid
muscle and overlying soft tissue is reduced.
Arguably, this causes less post-operative
patient discomfort, together with earlier
return of movement. However, the success of
the repair depends on the ability of the sur-
geon to achieve a secure attachment of ten-
don to bone. This may be more easily and
reliably achieved by open/mini-open surgery.
Other potential disadvantages of the
arthroscopic approach include increased
technical difficulty and longer time in theatre.
Only a few, small, non-randomised studies
have directly compared procedures and
therefore there is a need to compare the out-
come of the two surgical techniques.12 
The primary objective of this study is to
conduct a pragmatic multicentre random-
ised clinical trial to obtain good quality evi-
dence of the effectiveness and cost-
effectiveness of arthroscopic versus open
surgical repair for the treatment of degener-
ative rotator cuff tears. 
Materials and Methods
Design. At the outset of the UKUFF trial in
2007, a three-way parallel group randomised
trial began comparing arthroscopic rotator
cuff repair surgery with open or mini-open
rotator cuff repair surgery with a rest-then-
exercise programme of non-operative care
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[UKUFF Original REC Version Number 07/Q1606/49].
Figure 1 presents the original version as a flowchart.
The trial was adapted and reconfigured by the funder
in 2009, (after consultation with the trial steering and
data monitoring committees), into a two-way parallel
group RCT, due to a high rate of crossover of patients
(85%) from the rest-then-exercise programme to surgery
(UKUFF Reconfigured REC Reference Number 10/H0402/
24). A total of 87 patients were carried through to the
subsequent reconfigured trial. After the reconfiguration,
it was calculated that a further 180 patients should be
recruited and followed up for two years as per the origi-
nal protocol (providing a total of 267 patients treated
with surgery). It is the reconfigured design that is pre-
sented in this protocol.
UKUFF (reconfigured) is a pragmatic multicentre study
involving 20 surgeons from 16 UK centres. It includes
patients over 50 years of age, with a diagnosis of a full
thickness rotator cuff tear who are deemed eligible for
surgery. Patients are randomised to either open or
arthroscopic repair, while the surgeons perform their
usual and preferred surgical technique using one of these
approaches. Patients are followed up with telephone and
postal questionnaires for 24 months, and an MRI or USS
(Ultrasound Scan) 12 months after their surgery. The pri-
mary outcome is the Oxford Shoulder Score at
24 months.13 The study is led by clinicians (both surgeons
and physiotherapists), methodologists, statisticians and
health economists.
Surgeon eligibility. Participating surgeons require a
‘minimum level of expertise’ for the types of surgery
undertaken. For both surgical techniques, only consul-
tant orthopaedic shoulder surgeons with a minimum of
two years’ experience in consultant practice can partici-
pate. For those surgeons performing both arthroscopic
surgery and open surgery, only those who have per-
formed a minimum of five cases per year are considered
eligible. The participating surgeons represent a cross-sec-
tion of high, medium and low volume practitioners
undertaking both arthroscopic and open surgery. 
Recruitment and treatment allocation. Support from local
research networks is used, where possible, to help with
patient identification, recruitment and with obtaining
any required data from patient notes. The eligibility of the
patient is confirmed by the local consultant orthopaedic
surgeon. 
Patient eligibility. The patient is eligible for the study if: 
 Aged at least 50 years old;
 Suffer from a degenerative rotator cuff tear; 
 Have a full thickness rotator cuff tear;
 Rotator cuff tear diagnosed using MRI or ultrasound
scan;
 Able to consent.
The patient is excluded if any of the following apply: 
 Previous surgery on affected shoulder; 
 Dual shoulder pathology; 
 Traumatic tear;
 Significant problems in the other shoulder; 
Eight weeks after actual or planned surgery
telephone questionnaire
Two weeks after actual or planned surgery
telephone questionnaire
Eight months after entry into trial
postal follow-up questionnaire
24 months after entry into trial
postal follow-up questionnaire
12 months after entry into trial
postal follow-up questionnaire
Open surgeryArthroscopic surgery Rest then exercise programme 
Patient to decide whether to 
continue with planned surgery
Participant randomised
Patient diagnosed with rotator cuff tear using MRI or ultrasound scan
Patient fulﬁls inclusion parameters, signs consent form and completes baseline questionnaire
Fig. 1
Original trial flow chart.
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 Rheumatoid arthritis/systemic disease; 
 Significant osteoarthritis problems; 
 Significant neck problems;
 Cognitive impairment or language issues;
 Unable to undergo an MRI scan for any reason. 
There is no formal age limit. However, patients aged
85 years and over are not expected to be eligible to par-
ticipate. Consent is obtained either locally, by a research
nurse, or remotely by the study office in Oxford. Only
when the consent form and the baseline questionnaire
have been returned is the participant entered into the trial
and randomised to one of the surgical options. Randomi-
sation is by computer allocation at the Health Services
Research Unit, University of Aberdeen. Allocation was
minimised using surgeon, age and size of tear. After ran-
domisation, the participant is irrevocably part of the trial
for the purpose of the research, irrespective of what
occurs subsequently. 
Patients are free to withdraw at any time without con-
sequence to the health care they receive.
Randomised surgery. Details of the surgical technique
used (including method of repair and theatre equipment
used, e.g. types of suture) are recorded on a standard
form, as are the size of the tear, the appearance of the ten-
dons involved, and the ease and the completeness of the
repair. If circumstances dictate that the allocated surgical
technique cannot be carried out, then any alternative pro-
cedure is recorded. The surgeon contacts the study office
if their patient is unwilling or unable to have the opera-
tion on the arranged date. Patient progress through the
study is detailed in Figure 2.
Data collection and processing 
Outcome assessments involve patient-completed ques-
tionnaires and 12-month post-surgery imaging. 
Questionnaires. A combination of the Oxford Shoulder
Score (OSS),13 the Shoulder Pain and Disability Index
(SPADI),14 the Mental Health Inventory (MHI-5)15 and the
EQ-5D16 is used to assess functional outcome and
patient-reported quality of life. These assess a range of
symptoms often experienced with rotator cuff tears,
e.g. pain, weakness and a loss of function. Outcome
assessments are conducted by participant self-comple-
tion questionnaires and, as such, interviewer bias and
clinical-rater bias are avoided. This form of outcome mea-
surement has consistently performed well in comparison
Two and eight weeks after actual or planned surgery date
telephone questionnaire
Eight months after entry into trial
postal follow-up questionnaire
24 months after entry into trial
postal follow-up questionnaire
12 months after entry into trial
postal follow-up questionnaire
Open surgery/Mini-open surgeryArthroscopic surgery
Patient randomised
Patient diagnosed with rotator cuff tear deemed suitable for surgical repair
Patient meets inclusion criteria, signs consent form and completes baseline questionnaire
12 months post-surgery
MRI scan
Fig. 2
UKUFF trial flow chart.
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with clinician-based assessments and general health sta-
tus measures. All participants, including those who with-
draw from their allocated intervention but who still wish
to be involved in the study, are followed up with analysis
based on the intention to treat principle. 
Participants will receive questionnaires at the following
time points: 
 Baseline questionnaire – completed before randomi-
sation; 
 Two and eight weeks post treatment – questionnaire
completed over the phone; 
 Eight, 12 and 24 months post-randomisation. 
The baseline, 12- and 24-month post-randomisation
questionnaires also collect information to inform a cost-
effectiveness element. Questions relating to information
on primary care consultations, other consultations, out-
of-pocket costs and work impact of the intervention
received, are included. The study office in Aberdeen will
contact and follow up participants whose questionnaires
have not been returned.
Post-operative imaging. High rates of re-rupture of the
rotator cuff tear (20% to 54%) have been reported after
surgery, with some reporting a significant correlation
between re-rupture and poor outcome.17 Rates of re-
rupture or repair failure may differ between the two surgi-
cal techniques. For this reason, participants will undergo
an MRI or USS at 12 months post operation to assess the
state of the rotator cuff repair. These are arranged by the
study office in Oxford and performed locally. The images
are collected centrally and read by an independent consul-
tant radiologist blind to the type of surgery performed.
The results of the scan are not reported to the participating
surgeons. Incidental abnormalities of clinical significance
are reported to the surgeon.
Analysis
Statistical analyses are based on randomisation of
patients, irrespective of subsequent compliance with the
randomised intervention. The principal comparisons will
be all those allocated arthroscopic surgery versus all those
allocated open surgery. The analyst will be blinded to the
allocation. 
Measure of outcome. The primary outcome measure
used will be the OSS at 24 months after randomisation. 
The primary measure of cost-effectiveness will be the
incremental cost per quality-adjusted life year gained.
Secondary outcome measures include: 
 OSS at 12 months after randomisation; 
 EQ-5D16 at eight, 12, 24 months after randomisation; 
 MHI-515 at eight, 12, 24 months after randomisation; 
 SPADI14 at eight, 12, 24 months after randomisation;
 Participant’s rating of how pleased they are with
shoulder symptoms at 12, 24 months after randomi-
sation; 
 Participant’s view of state of shoulder at eight, 12,
24 months after randomisation; 
 Surgical complications (intra- and post-operative) at
two and eight weeks post surgery and at 12 and
24 months after randomisation; 
 Net health care costs at two weeks, 12 and 24 months
after randomisation; out-of-pocket costs and work
impact.
Planned subgroup analyses. i) Size of tear (small/medium
versus large/massive); ii) Age < or equal to 65 or > 65. 
Stricter levels of statistical significance (p < 0.01) will be
used in subgroup analyses reflecting their exploratory
nature and the multiple testing involved. 
Statistical analysis. Reflecting the possible clustering in
the data, the outcomes will be compared using multilevel
models, with adjustment for minimisation variables and
participant baseline values. Statistical significance is set at
the 2.5% level, with corresponding confidence intervals.
All participants will remain in their allocated group for
analysis (intention to treat). Per-protocol analysis will also
be performed.
Economic evaluation. A cost-effectiveness analysis will
be performed. A simple patient resource-use question-
naire at baseline and at 12 and 24 months post randomi-
sation is used to obtain information on primary care
consultations, other consultations, out-of-pocket costs,
work impact of the intervention received and return to
work. Unit costs will come from national sources and par-
ticipating hospitals. The patient questionnaire is also
used to administer the EQ-5D. The main health economic
outcome is within-trial and extrapolated quality-adjusted
life years, estimated using the EQ-5D. 
Incremental cost effectiveness will be calculated as the
net cost per quality-adjusted life year gained, for
arthroscopic surgery versus open surgery. Power calcula-
tions (see following section) have been based on clinical
rather than cost effectiveness outcomes, which will be
estimated rather than used in hypothesis testing. Cost-
effectiveness ratios and net-benefit statistics will be calcu-
lated. We will report within-trial cost-effectiveness and
explore if the trial produces sufficient evidence to plausi-
bly model future quality of life or costs (e.g. based on pro-
jected failure rates). We will also extrapolate long-term
cost effectiveness beyond the trial period. 
An important component of this trial will be assessment
of cost. Therefore, an accurate record of procedures at each
of the proposed centres is essential. To evaluate costs of
each type of surgery, information from the operating the-
atres will be collected. Theatre managers will be contacted
and visited at each site. Resources used, equipment costs
and standard procedures for rotator cuff repairs will be
recorded. Per-case information will also be analysed during
the final analysis. A checklist of equipment, consumables,
implants, time and staff used during each case will be
completed by theatre staff. Information from theatres will
be collected by the Oxford UKUFF office and will be used in
a cost comparison between the arthroscopic and open
surgery. 
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Sample size and feasibility 
Sample size sought. The sample size was designed to
detect a difference in OSS score of 0.38 of a standard devia-
tion (SD) for the comparison of arthroscopic versus open sur-
gery. This was based on our experience of using and
developing the OSS score in a variety of settings, from which
a three-point difference (0.33 of a SD) would be deemed a
clinically important change. Attrition is expected to be low
(10%), as are the effects of clustering of outcomes18,19 (intra
cluster correlation (ICC) less than 0.03). While we did not
have a direct estimate from a shoulder trial, other orthopae-
dic datasets available to our team supported this low ICC
estimate. Both of these factors required the sample size to be
inflated, however, the primary analysis will be adjusted for
baseline OSS score which conversely allows the sample size
to be decreased by a factor of 1-correlation squared.20 Our
previous studies showed that the correlation in the OSS
score pre surgery to six months post surgery in patients sim-
ilar to potential trial participants was 0.57. Assuming a con-
servative correlation of 0.5 implied that the sample size
could be reduced by 25%, and still maintains the same
power. Therefore, a study with a total of 267 participants
was considered sufficiently powered to detect a clinically
important change in each comparison, assuming attrition
and clustering accounted for approximately 25% of varia-
tion in the data. 
Organisation
Trial Timeline. The trial began in December 2007 and
was stopped in December 2009 to allow for reconfigura-
tion. Funding approval of the reconfiguration was given
in January 2010 and revised research ethics approval was
granted in April 2010. In May 2010, recruitment started to
the reconfigured design. The final follow-up assessment
was planned for December 2013. Analysis and write up
are planned for January 2014 to July 2014, with publica-
tion and dissemination from August 2014 onwards.
Central organisation of the study. Oxford co-ordinates
the site-specific and clinical concerns, while Aberdeen
houses the database and randomisation systems. The
study is overseen by an independent Trial Steering Com-
mittee and an independent Data Monitoring Committee. 
Protocol amendments. Small changes have been made to
the protocol over time, to reflect changes in points of out-
come data collection and recruitment procedures. Some
changes have been made in response to alterations in wait-
ing times for surgery in the NHS that occurred during the
trial period. Support for individual centres also changed
after the inception of the NIHR in the UK and the provision
of a regional network of research support through the UK
Comprehensive Research Network (UKCRN).
Publication 
The investigators will be involved in reviewing drafts of
the manuscripts, abstracts, press releases and any other
publications arising from the study. Authors will
acknowledge that the study was funded by the NIHR HTA
programme. Authorship will be determined in accor-
dance with the ICMJE guidelines and other contributors
will be acknowledged. The main report will be drafted by
the UKUFF Management Group, and the final version will
be agreed by the Trial Steering Committee before submis-
sion for publication, on behalf of the UKUFF collaborators. 
Trial status. UKUFF completed recruitment in February
2012, with follow-up completed in January 2014. Produc-
tion of the monograph is planned for July 2014.
Trial sponsorship and registration. Trial co-sponsors are
The University of Oxford, Joint Research Office, Churchill
Hospital, Headington, Oxford and University of Aberdeen,
University Office, King’s College, Regent Walk, Aberdeen. 
International Standard Randomised Controlled Trial
Number (ISRCTN): ISRCTN97804283.
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